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aBstRaCt Escherichia coli can cause severe respira-
tory and systemic infections in chickens, and it is of-
ten associated with significant economic losses in the 
poultry industry. Bacteriophages (phages) have been 
shown to be potential alternatives to the antibiotics 
in the treatment of bacterial infections. To accomplish 
that, phage particles must be able to reach and remain 
active in the infected organs. The present work aims 
at evaluating the effect of the route of administration 
and the dosage in the dissemination of 3 coliphages in 
the chicken’s organs. In vivo trials were conducted by 
infecting chickens orally, spray, and i.m. with 106, 107, 
and 108 plaque-forming units/mL suspensions of 3 lytic 
phages: phi F78E (Myoviridae), phi F258E (Siphoviri-
dae), and phi F61E (Myoviridae). Birds were killed 3, 
10, and 24 h after challenge and the phage titer was 
measured in lungs and air sacs membranes, liver, duo-
denum, and spleen. When administered by spray, the 
3 phages reached the respiratory tract within 3 h. Oral 
administration also allowed all phages to be recovered 
in lungs, but only phi F78E was recovered from the du-
odenum, the liver, and the spleen. These differences can 
be explained by the possible replication of phi F78E in 
commensal E. coli strains present in the chicken gut, 
thus leading to a higher concentration of this phage in 
the intestines that resulted in systemic circulation of 
phage with consequent phage in organs. When phages 
were administered i.m., they were found in all of the 
collected organs. Despite this better response, i.m. ad-
ministration is a nonpracticable way of protecting a 
large number of birds in a poultry unit. In general, 
the results suggest that oral administration and spray 
allowed phages to reach and to remain active in the re-
spiratory tract and can, therefore, be considered prom-
ising administration routes to treat respiratory E. coli 
infections in the poultry industry.
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IntRoduCtIon
Colibacillosis, caused by Escherichia coli, is a severe 
infection of farmed poultry leading to high morbidity 
and mortality. This infection appears especially after 
other respiratory diseases, such as infectious bronchitis 
or mycoplasmosis, and is frequently associated with im-
munosuppressive diseases such as infectious bursal dis-
ease virus (Gumboro disease; Barnes and Gross, 1997). 
The increasing incidence of antibiotic resistances in E. 
coli and the restriction of the use of antibiotics in ani-
mal production (Huff et al., 2004) emphasize the im-
portance of the evaluation of alternative antimicrobial 
therapies.
Once bacteriophages (phages) are obligatory and ex-
clusive bacterial parasites, they can act as antimicro-
bial agents, a fact that has encouraged researchers to 
test their potential as therapeutic agents. Phages are 
ubiquitous in nature and are known to inhabit animals 
and humans. Phages penetrate the blood stream and 
other tissues very freely upon their administration by 
different routes. The potential of phages as antibac-
terial agents lies on their ability to destroy bacterial 
cells at the end of an infectious cycle. The simultane-
ous releasing of the progeny leads to a concentration of 
phages in the places where bacterial infection occurs, 
retaining their full biological activity (Dabrowska et al., 
2005). Moreover, phage therapy only needs to decrease 
the number of infecting bacteria to a level that allows 
the host defenses to overcome the remaining infection 
(Levin and Bull, 2004).
However, phage therapy may fail if phages are un-
able to reach the target organs in the concentrations 
needed to trigger the infection cycle. Phages might be 
intolerant to the gastrointestinal tract conditions or in-
activated by the immune system. Therefore, it is of ut-
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most importance to understand the dynamics of phage 
dissemination in the target organism to predict the 
success of phage therapy. In this study, the dissemina-
tion of 3 different coliphages was assessed, taking into 
account the phage type, the administration route, and 
the dosage.
mateRIals and metHods
Bacteriophage Amplification
The phages used in this study were isolated from 
poultry sewage and screened against a pool of 148 avi-
an pathogenic E. coli (APEC) strains. Phi F78E, phi 
F258E, and phi F61E were, respectively, lytic for 34.9, 
23.5, and 45.0% of APEC strains and the 3 phages as-
sociated were active against 70.5% of the strains (Ol-
iveira et al., 2008). The morphological characterization 
of the phages revealed that phi F78E and phi F61E, 
are 16–19-type phages, having capsids of 103 × 42 nm 
and contractile tails of 100 × 17 nm and both belong 
to Myoviridae. Although morphologically similar, they 
were shown to be genetically different (Oliveira et al., 
2008). The other phage, phi F258E, is a Siphoviridae, 
T1-like phage with a circular head of 62-nm diameter 
and a flexible tail of 160 × 8 nm (Oliveira et al., 2008). 
Phage replication was performed by inoculating 10 mL 
of each phage in 100 mL of the E. coli hosts H561E, 
H816E, and H161E, respectively, for phages phi F78E, 
phi F61E, and phi F258E and mid-log grown in Luria-
Bertani (LB) broth. This was followed by an overnight 
incubation at 37°C with shaking (120 rpm). This sus-
pension was then centrifuged at 9,000 × g for 10 min 
(rotor 19776, Sigma 3-16k, St. Louis, MO), filtered 
through a 0.22-µm membrane and stored at 4°C.
The bacteriophage concentration was determined ac-
cording to the plaque assay method described by Ad-
ams (1959). A volume of 100 µL of successive dilutions 
of the phage suspension was mixed with 100 µL of the 
respective bacteria host suspension (3- to 4-h culture) 
and 3 mL of LB 0.6% melted agar. This suspension was 
poured onto a 1.5% LB agar plate and incubated at 
37°C overnight. The suspension volume was adjusted to 
obtain the desired phage concentration.
Experimental Design
Experiments were designed and conducted in ac-
cordance with the Federation of European Laboratory 
Animal Science Associations principles and the specific 
guidelines of animal welfare (Van Zutphen et al., 2001), 
based on the European Council Directive of 24 Novem-
ber 1986 (86/609/EEC) guidelines regarding the pro-
tection of animals used for scientific experimental pur-
poses. According to those principles, the lowest number 
of animals necessary to reach the proposed goal in an 
in vivo experiment must be used. A total of 94 healthy 
7-wk-old female growers (Rhode Island Red), obtained 
in a local poultry house, were housed in batteries and 
subjected to a 5-d acclimation period. The chickens 
were monitored for the presence of commensal enter-
obacteria sensitive to phi F258E, phi F61E, and phi 
F78E. For that purpose, cloacae swabs were collected 
in triplicate, plated in MacConkey agar (selective and 
differential medium for gram-negative bacteria), and 
incubated at 37°C. Five to 8 pink colonies (microor-
ganisms that ferment lactose, as E. coli) were selected 
and picked from each plate, incubated separately in 10 
µL of LB broth at 37°C for 3 to 4 h, and spread on a 
lawn. Then, they were tested for phage sensitivity: 20 
µL of phage was dropped on these bacteria lawns and 
incubated at 37°C overnight. Plates were then checked 
for clear zones.
Parallel trials were conducted to determine the effi-
cacy of phage administration to chicken organism, con-
cerning the route (oral, spray, and i.m.) and the dosage 
[1 × 106, 1 × 107, and 1 × 108 plaque-forming units 
(pfu)/mL]. Feed and water was available ad libitum. 
Groups of 3 animals were challenged with 1 mL of the 
phage suspension at each of the indicated phage con-
centration, orally with a syringe, by spray directly to 
the beak, or i.m. by injection in the chest muscle. One 
group, not challenged with the phages, was used as a 
control group. Birds were killed by isoflorane inhalation 
(IsoFlo, Abbott, Abbott Park, IL; Close et al., 1997) 
3, 10, and 24 h after challenge. At necropsy, carcasses 
were dissected and different organs and tissues (lungs 
and air sac membranes, liver, duodenum, and spleen) 
were carefully excised, weighed, and emulsified individ-
ually in LB broth at 1:10 (wt/vol). The supernatants 
were decanted, centrifuged at 9,000 × g for 10 min, and 
filtered through 0.22 µm. The phage concentration was 
measured in each sample, as described above.
Results
Bacteriophage Distribution in Chicken 
Organisms
Preliminary studies to detect host-susceptible strains 
to the 3 studied coliphages revealed the presence of a 
commensal E. coli strain susceptible to phi F78E.
The results of phage detection in the animal organs 
after oral and spray administration are presented in Ta-
bles 1 and 2, respectively. When administered by spray, 
all 3 phages reached the respiratory organs. The oral 
administration also allowed phi F61E and phi F258E to 
reach the lungs and the air sac membranes, being recov-
ered from these organs at least at 10 h from challenge. 
The phage phi F78E remained in the same organs for 
the whole tested period when administered at 108 pfu/
mL. Phi F78E was recovered from the duodenum at 
least 3 h after the oral administration of 107 and 108 
pfu/mL suspensions; however, it was not possible to 
recover the other 2 phages (phi F61E and phi F258E) 
in this organ. Nevertheless, when spray administration 
was employed, all phages were found in the duodenum, 
and phi F78E titers were higher than the other phages 
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(data not shown). Phi F78E could be isolated from the 
liver and spleen after oral and spray administration.
The presence of phages in organs after i.m. injection 
is shown in Table 3. All of the phages were recovered 
from the chicken lungs and air sac membranes, the liv-
er, and the spleen at least 3 h after challenge (except 
for phi F61E, not found in the liver when administered 
at 106 pfu/mL). Phages remained in the spleen for all 
of the experimental period. When injected at 108 pfu/
mL, all of the phages reached the intestine. Figure 1 
presents the concentrations of phi F78E, phi F258E, 
and phi F61E recovered in the lungs and air sacs, the 
liver, and the spleen after i.m. injection of 1 × 108 pfu. 
Data refer to phage enumeration at 3, 10, and 24 h of 
challenge.
In general, all of the phages were rescued in the 
spleen, the liver, and the lungs 3 h postadministration, 
with the maximum concentration of phi F78E and phi 
F258E observed in the spleen and of phi F61E in the 
liver.
Concerning the phage titers measured in the chick-
en’s lungs, it was observed that, for all administered 
concentrations and for all of the phages, the higher-
phage titers were detected 3 h after phage administra-
tion. On the contrary, 10 h after challenge, no phage 
was detected in these organs.
dIsCussIon
Extraintestinal pathogenic E. coli, called APEC, pos-
sess specific virulence attributes commonly causing re-
spiratory and systemic infections in poultry (chickens 
and turkeys), namely colibacillosis (Barnes and Gross, 
1997; Zhao et al., 2005). In a phage therapy perspec-
tive, phages must be able to reach the infected organs, 
a fact that might be dependent on the mode of admin-
istration, the administration titer, and the phage itself. 
In fact, the overall results presented in this manuscript 
demonstrate that the phage type, the administration 
route, and the dose delivered were all factors in con-
tributing to variability of bacteriophage dissemination 
in tissues.
Phages have been administered orally, topically, by 
spray, directly into body tissues, or systemically (Smith 
and Huggins, 1982, 1983; Berchieri et al., 1991; Soothill, 
1994; Barrow et al., 1998; Sklar and Joerger, 2001; Huff 
et al., 2002, 2003a,b, 2004; Park and Nakai, 2003; Hig-
gins et al., 2005). The method chosen for phage ad-
ministration must guarantee the contact between phage 
Table 1. Presence (+) or absence (−) of phages in organs and tissues after oral administration, according to the initial phage con-
centration and the time of slaughter (3, 10, and 24 h)1 
Phage count, pfu/mL2
Phi F78E Phi F258E Phi F61E
A B C D A B C D A B C D
108 +++ −+− +−− −−+ −+− −−− −−− −−− −−− −−− −−− −−−
107 ++− +−− ++− +−− −++ −−− −−− −−− −+− −−− −−− −−−
106 −−− −−− −−− −−− −−− −−− −−− −−− −−− −−− −−− −−−
1A = lungs and air sacs; B = liver; C = duodenum; D = spleen.
2pfu = plaque-forming unit.
Table 2. Presence (+) or absence (−) of phages in organs and tissues after spray administration, according to the initial phage con-
centration and the time of slaughter (3, 10, and 24 h)1 
Phage count, pfu/mL2
Phi F78E Phi F258E Phi F61E
A B C D A B C D A B C D
108 +++ −−− ++− −−− ++− −−− +−− −−− +−− −−− +−− −−−
107 ++− +−− ++− −+− ++− −−− −−− −−− −−− −−− +−− −−−
106 ++− +−− +−− +−− −−− −−− −−− −−− −−− −−− +−− −−−
1A = lungs and air sacs; B = liver; C = duodenum; D = spleen.
2pfu = plaque-forming unit.
Table 3. Presence (+) or absence (−) of phages in organs and tissues after i.m. administration, according to the initial phage con-
centration and the time of slaughter (3, 10, and 24 h) 
Phage count, pfu/mL2
Phi F78E Phi F258E Phi F61E
A B C D A B C D A B C D
108 ++− +++ +++ +++ +−− ++− ++− +++ +−− ++− −+− +++
107 ++− +++ −−− +++ +−− +−− −−− +++ +−− +−− +−− +++
106 +++ ++− −+− +++ +−− +−− −+− +++ +−− −−− −−− +++
1A = lungs and air sacs; B = liver; C = duodenum; D = spleen.
2pfu = plaque-forming unit.
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particles and target pathogens. It is therefore impor-
tant to ensure that, whatever route of administration, 
phage delivery to the infected organs will take place. 
In the particular case of avian respiratory infections 
caused by APEC, phages must be able to reach lungs 
and air sac membranes. On the other hand, from the 
practical point of view, some routes, like systemic ones, 
would be unfeasible, due to the large number of birds in 
a poultry unit. In this specific case, the most practical 
methods would be oral inoculation in feed or water or 
aerosol (spray) delivery of phages. In fact, other man-
agement practices employ one or both of these routes 
for suspension delivery, like most of the vaccine ap-
plication (Cargill and Johnston, 2006) or some antibi-
otic and probiotic administration (Gillingham, 2006). 
Oral administration, however, could be considered an 
obstacle due to the potential phage inactivation during 
its passage through the acidic gut compartments (Ma 
et al., 2008).
Nevertheless, the experiments herein reported re-
vealed the presence of phi F78E in all of the emulsified 
organs, after oral administration; however, this phage 
is susceptible to low pH values (data not shown). This 
apparent absence of deleterious effects of the low pH on 
the phages might be explained by the diluting effect of 
water-feed intake (ad libitum intake) on the digestive 
system that could raise the pH in gizzard and proven-
triculus (Van der Klis et al., 1993).
Another important aspect to consider is the fact that 
phi F78E was the phage recovered in higher amounts, 
compared with the other 3 phages, after oral or spray 
administration. This phage had a commensal E. coli 
host strain in the intestine and might have replicated 
there. This could be the reason why this phage reached 
and remained in the studied organs at higher titers 
for longer periods, being the only one that apparently 
reached the bloodstream. Based on this result, it can 
also be speculated that there may be an advantage of 
administering a nonpathogenic bacterial host together 
with the phage to ensure its amplification in the gut.
The ability of this phage to infect commensal E. coli 
strains can be advantageous in a phage therapy context 
because high internal titers of the phage are obtained. 
On the other hand, by infecting commensal strains, the 
phage might impair the flora equilibrium.
The presence of phages phi F258E and phi F61E in 
the respiratory tract after oral administration cannot 
be explained by their penetration into the bloodstream 
through the intestinal mucosa after reaching the duo-
denum because they were not rescued by liver or spleen 
filters against foreign organisms that enter the blood-
stream. Thus, phages might have reached chickens’ 
lungs and air sacs probably due to the inhalation of 
aerosols or suspension droplets during the administra-
tion. Relative to phi F78E, aerosols might have been 
formed and breathed as well from the dust of the cages, 
where the concentration of this particular phage should 
be higher (due to the presence of an intestinal host 
strain). Conversely to the other 2 phages, phi 78E was 
found in the liver and spleen when given orally to chick-
ens, as well as in the duodenum, the segment of the 
small intestine with a higher absorption rate, indicat-
ing its absorption through the intestinal mucosa. Some 
researchers (Weber-Dabrowska et al., 1987; Dabrows-
ka et al., 2005; Górski and Weber-Dabrowska, 2005; 
Górski et al., 2006) reported that orally administered 
phages can reach the peripheral blood and migrate to 
the infection sites. The phage occurrence in the blood 
is also supported by several authors (Merril et al., 1996; 
Figure 1. Concentration (pfu/mL) of phi F78E (A), phi F258E 
(B), and phi F61E (C) found in lungs and air sacs, liver, and spleen 
after 3, 10, and 24 h of the i.m. administration of 1 × 108 pfu/mL. The 
inset in panel A illustrates, in an amplified scale, the values of phage 
concentration in organs at 10 h postadministration.
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Dabrowska et al., 2005; Górski and Weber-Dabrowska, 
2005).
Spray administration allowed all phages to reach the 
respiratory tract. This may be a promising route of 
administration allowing phages to reside in the tissues 
and membranes where the pathogenic bacteria are lo-
cated. Huff et al. (2003b) also reported the presence of 
phages in the respiratory tract after aerosol administra-
tion. The fact that with this route of administration 
phages reached the chicken duodenum is probably due 
to the spray swallowing. This route allowed phi F78E 
to circulate in the bloodstream, reaching all organs. 
Three hours after challenging the chickens i.m., it was 
possible to find the 3 phages in all organs including 
lungs and air sacs. This is an important indicator for 
therapy, once phages can rapidly reach the target or-
gans of infection for pathogenic E. coli. However, these 
results indicate that although phages rapidly dissemi-
nated in the animal organs (at least 3 h after challenge) 
reaching the infected tissues, they were quickly cleared 
by the chicken organism. In fact, all of the phages were 
cleared from lungs after 10 h. So, for practical purpos-
es, it can be hypothesized that in this particular case, 
phage therapy of respiratory infections is only efficient 
immediately after phage administration and the fact 
that phages would not confer protection against E. coli 
after 10 h might compromise their use as prophylactic 
agents.
Whatever the route of administration, as expected, 
the phage dosage seemed also to be an important fac-
tor for phage therapy in vivo efficiency. Results suggest 
that the initial concentration of phages administered 
i.m. was directly proportional to the quantity of phag-
es that reached the potentially affected organs (data 
not shown). A dose-dependence effect was reported by 
several authors in phage efficacy studies and modeling 
(Payne and Jansen, 2001; Biswas et al., 2002; Weld et 
al., 2004).
Summarizing, phage dissemination into the chicken 
organs is highly dependent on the dosage and route 
of administration. The presence of commensal bacteria 
might also play an important role in phage spreading. 
Spray and oral phage administration enables phages to 
reach the chicken respiratory tract and therefore can be 
considered important administration routes to control 
E. coli respiratory infections.
aCKnoWledgments
We thank the Portuguese Foundation for Science and 
Technology (Lisboa, Portugal) that partially supported 
this work through the grant SFRH/BDE/15508/2004.
ReFeRenCes
Adams, M. H. 1959. Bacteriophages. Interscience Publishers, New 
York, NY.
Barnes, H. J., and W. B. Gross. 1997. Colibacillosis. Pages 131–141 
in Diseases of Poultry. B. W. Calnek, H. J. Barnes, C. W. Beard, 
L. R. McDougald, and Y. M. Saif, ed. Iowa State University 
Press, Ames.
Barrow, P., M. Lovell, and A. Berchieri Jr. 1998. Use of lytic bacte-
riophage for control of experimental Escherichia coli septicemia 
and meningitis in chickens and calves.  Clin. Vaccine Immunol. 
5:294–298.
Berchieri, A., M. A. Lovell, and P. A. Barrow. 1991. The activity in 
the chicken alimentary tract of bacteriophage lytic for Salmonella 
Typhimurium.  Res. Microbiol.  142:541–549.
Biswas, B., S. Adhya, P. Washart, B. Paul, N. Trostel, B. Powell, R. 
Carlton, and C. R. Merril. 2002. Bacteriophage therapy rescues 
mice bacteremia from a clinical isolate of vancomycin-resistant 
Enterococcus faecium.  Infect. Immun.  70:204–210.
Cargill, P. W., and J. Johnston. 2006. Vaccine Administration to 
Poultry Flocks. Merial, Gainesville, GA.
Close, B., K. Banister, V. Baumans, E.-M. Bernoth, N. Bromage, J. 
Bunyan, W. Erhardt, P. Flecknell, N. Gregory, H. Hackbarth, D. 
Morton, and C. Warwick. 1997. Recommendations for euthana-
sia of experimental animals: Part 2. Pages 10–14 in Laboratory 
Animals. University of Oxford, Oxford, UK.
Dabrowska, K., K. Switaa-Jelen, A. Opolski, B. Weber-Dabrowska, 
and A. Górski. 2005. Bacteriophage penetration in vertebrates. 
J. Appl. Microbiol.  98:7–13.
Gillingham, S. 2006. Antibiotic/Probiotic Trends and Transitions 
in the Poultry Industry. Alberta Agriculture, Food And Rural 
Development, Edmonton, Alberta, Canada.
Górski, A., E. Wazna, B. W. Dabrowska, K. Dabrowska, K. Switała-
Jeleń, and R. Miedzybrodzki. 2006. Bacteriophage translocation. 
FEMS Immunol. Med. Microbiol.  46:313–319.
Górski, A., and B. Weber-Dabrowska. 2005. The potential role of en-
dogenous bacteriophages in controlling invading pathogens.  Cell. 
Mol. Life Sci.  62:511–519.
Higgins, J. P., S. E. Higgins, K. L. Guenther, W. Huff, A. M. Dono-
ghue, D. J. Donoghue, and B. M. Hargis. 2005. Use of a specific 
bacteriophage treatment to reduce Salmonella in poultry prod-
ucts.  Poult. Sci.  84:1141–1145.
Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Dono-
ghue. 2002. Prevention of Escherichia coli infection in broiler 
chickens with a bacteriophage aerosol spray.  Poult. Sci.  81:1486–
1491.
Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Dono-
ghue. 2003a. Bacteriophage treatment of a severe Escherichia coli 
respiratory infection in broiler chickens.  Avian Dis.  47:1399–
1405.
Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Dono-
ghue. 2003b. Evaluation of aerosol spray and intramuscular in-
jection of bacteriophage to treat an Escherichia coli respiratory 
infection.  Poult. Sci.  82:1108–1112.
Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Dono-
ghue. 2004. Therapeutic efficacy of bacteriophage and Baytril 
(enrofloxacin) individually and in combination to treat colibacil-
losis in broilers.  Poult. Sci.  83:1944–1947.
Levin, B. R., and J. J. Bull. 2004. Population and evolutionary dy-
namics of phage therapy.  Nat. Rev. Microbiol.  2:166–173.
Ma, Y., J. C. Pacan, Q. Wang, Y. Xu, X. Huang, A. Korenevsky, 
and P. M. Sabour. 2008. Microencapsulation of bacteriophage 
Felix O1 into chitosan-alginate microspheres for oral delivery. 
Appl. Environ. Microbiol.  74:4799–4805.
Merril, C. R., B. Biswas, R. Carlton, N. C. Jensen, G. J. Creed, S. 
Zullo, and S. Adhya. 1996. Long-circulating bacteriophage as an-
tibacterial agents.  Proc. Natl. Acad. Sci. USA  93:3188–3192.
Oliveira, A., S. Sillankorva, A. Henriques, R. Quinta, R. Sereno, 
and J. Azeredo. 2008. Isolation and characterization of bacterio-
phages for avian pathogenic E. coli strains.  J. Appl. Microbiol. 
10.1111/j.1365-2672.2009.04145.x
Park, S. C., and T. Nakai. 2003. Bacteriophage control of Pseudomo-
nas plecoglossicida infection in ayu Plecoglossus altivelis.  Dis. 
Aquat. Organ.  53:33–39.
Payne, R. J. H., and V. A. A. Jansen. 2001. Understanding bacterio-
phage therapy as a density-dependent kinetic process.  J. Theor. 
Biol.  208:37–48.
Sklar, I. B., and R. D. Joerger. 2001. Attempts to utilize bacterio-
phage to combat Salmonella enterica serovar Enteritidis infection 
in chickens.  J. Food Saf.  21:15–29.
OLIVEIRA ET AL.6
Smith, H. W., and M. B. Huggins. 1982. Successful treatment of 
experimental Escherichia coli infections in mice using phage: Its 
general superiority over antibiotics.  J. Gen. Microbiol.  128:307–
318.
Smith, H. W., and M. B. Huggins. 1983. Effectiveness of phages in 
treating experimental Escherichia coli diarrhoea in calves, piglets 
and lambs.  J. Gen. Microbiol.  129:2659–2675.
Soothill, J. S. 1994. Bacteriophage prevents destruction of skin grafts 
by Pseudomonas aeruginosa.  Burns  20:209–211.
Van der Klis, J. D., A. Van Voorst, and C. Van Cruyningen. 1993. 
Effect of a soluble polysaccharide (carboxy methyl cellulose) 
on the absorption of minerals from the gastrointestinal tract of 
broilers.  Br. Poult. Sci.  34:971–983.
Van Zutphen, L. F. M., V. Baumans, and A. C. Beynen. 2001. Prin-
ciples of Laboratory Animal Science. 2nd ed. Elsevier, Amster-
dam, the Netherlands.
Weber-Dabrowska, B., M. Dabrowski, and S. Slopek. 1987. Stud-
ies on bacteriophage penetration in patients subjected to phage 
therapy.  Arch. Immunol. Ther. Exp. (Warsz.)  35:563–568.
Weld, R. J., C. Buttsc, and J. A. Heinemann. 2004. Models of phage 
growth and their applicability to phage therapy.  J. Theor. Biol. 
227:1–11.
Zhao, S., J. J. Maurer, S. Hubert, J. F. DeVillena, P. F. McDermott, 
J. Meng, S. Ayers, L. English, and D. G. White. 2005. Antimicro-
bial susceptibility and molecular characterization of avian patho-
genic Escherichia coli isolates.  Vet. Microbiol.  107:215–224.
DISSEMINATION OF COLIPHAGES IN CHICKENS 7
